474.14
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SNPS?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$480.64
Offen:
$480.665
24-Stunden-Volumen:
1.48M
Relative Volume:
0.76
Marktkapitalisierung:
$90.83B
Einnahmen:
$8.67B
Nettoeinkommen (Verlust:
$772.31M
KGV:
109.69
EPS:
4.3224
Netto-Cashflow:
$2.63B
1W Leistung:
-9.32%
1M Leistung:
-1.12%
6M Leistung:
+13.83%
1J Leistung:
+4.58%
Synopsys Inc Stock (SNPS) Company Profile
Firmenname
Synopsys Inc
Sektor
Branche
Telefon
(650) 584-5000
Adresse
675 ALMANOR AVE, SUNNYVALE, CA
Compare SNPS vs MSFT, ORCL, PLTR, CRWD, FTNT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SNPS
Synopsys Inc
|
474.38 | 92.03B | 8.67B | 772.31M | 2.63B | 4.3224 |
|
MSFT
Microsoft Corp
|
442.67 | 3.17T | 318.27B | 125.22B | 72.92B | 16.79 |
|
ORCL
Oracle Corp
|
222.94 | 585.85B | 64.08B | 16.40B | -24.74B | 5.5698 |
|
PLTR
Palantir Technologies Inc
|
155.79 | 343.63B | 5.22B | 2.29B | 2.69B | 0.8876 |
|
CRWD
Crowdstrike Holdings Inc
|
729.13 | 170.79B | 4.81B | -181.85M | 1.24B | -0.7398 |
|
FTNT
Fortinet Inc
|
137.38 | 95.02B | 7.11B | 1.95B | 2.44B | 2.5883 |
Synopsys Inc Stock (SNPS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-27 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2026-02-20 | Herabstufung | HSBC Securities | Buy → Hold |
| 2026-01-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-12-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-12-09 | Hochstufung | Rosenblatt | Neutral → Buy |
| 2025-12-08 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-11-24 | Eingeleitet | Citigroup | Buy |
| 2025-09-10 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-09-10 | Bestätigt | Needham | Buy |
| 2025-09-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-09-10 | Herabstufung | Rosenblatt | Buy → Neutral |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-01-13 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-11-12 | Eingeleitet | Loop Capital | Buy |
| 2024-10-22 | Eingeleitet | Mizuho | Outperform |
| 2024-10-15 | Eingeleitet | Berenberg | Buy |
| 2024-04-04 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-30 | Bestätigt | Needham | Buy |
| 2023-11-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-09-29 | Eingeleitet | HSBC Securities | Buy |
| 2022-12-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-16 | Eingeleitet | Edward Jones | Hold |
| 2022-09-29 | Eingeleitet | Deutsche Bank | Buy |
| 2022-09-08 | Eingeleitet | Stifel | Buy |
| 2022-08-17 | Eingeleitet | Wolfe Research | Outperform |
| 2022-06-29 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-10 | Bestätigt | BofA Securities | Underperform |
| 2021-10-20 | Eingeleitet | Needham | Buy |
| 2021-09-17 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-09-17 | Fortgesetzt | Rosenblatt | Buy |
| 2021-06-02 | Eingeleitet | Rosenblatt | Buy |
| 2021-01-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-08-20 | Bestätigt | Credit Suisse | Outperform |
| 2020-08-20 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-08-20 | Bestätigt | Needham | Buy |
| 2020-08-20 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-08-20 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-20 | Bestätigt | Wells Fargo | Overweight |
| 2020-05-27 | Eingeleitet | UBS | Buy |
| 2020-02-20 | Bestätigt | Needham | Buy |
| 2020-02-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-09-11 | Fortgesetzt | JP Morgan | Neutral |
| 2019-08-22 | Bestätigt | Needham | Buy |
| 2019-05-15 | Eingeleitet | Wells Fargo | Outperform |
| 2019-04-10 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2019-04-03 | Bestätigt | Needham | Buy |
| 2019-03-28 | Bestätigt | Needham | Buy |
| 2018-12-06 | Bestätigt | Needham | Buy |
| 2018-12-06 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2018-11-20 | Eingeleitet | Berenberg | Buy |
| 2018-10-23 | Hochstufung | JP Morgan | Underweight → Neutral |
Alle ansehen
Synopsys Inc Aktie (SNPS) Neueste Nachrichten
SBI Okasan Asset Management Co.Ltd. Makes New $1.70 Million Investment in Synopsys, Inc. $SNPS - MarketBeat
Synopsys appoints Elliott partner to board - Engineering.com
Ilmarinen Mutual Pension Insurance Co Cuts Holdings in Synopsys, Inc. $SNPS - MarketBeat
Synopsys Stock: A Powerful Moat Full Of Uncertainties (NASDAQ:SNPS) - Seeking Alpha
Geode Capital Management LLC Raises Stake in Synopsys, Inc. $SNPS - MarketBeat
Synopsys down, despite earnings beat - marketscreener.com
Is It Too Late To Consider Synopsys (SNPS) After Recent Valuation Concerns? - Yahoo Finance
Between AppLovin and Synopsys, Which Stock Looks Set to Break Out? - Trefis
Synopsys Stock To $337? - Trefis
Synopsys Inc (SNPS) Shares Fall 8.6% -- What GF Score of 95 Tells Investors - GuruFocus
Research Alert: CFRA Maintains Buy Rating On Shares Of Synopsys, Inc. - Moomoo
Citigroup Boosts Synopsys (NASDAQ:SNPS) Price Target to $610.00 - MarketBeat
Synopsys Gains Momentum on AI-Driven Chip Design Demand - Kalkine Media
Market movers: Dell, Immunic, Dollar Tree, Synopsys, Best Buy, Giyani Metals... - Proactive financial news
Synopsys Inc Stock (SNPS) Moved Down by 9.11% on May 28: Drivers Behind the Movement - TradingKey
Stock Market Today, May 28: Tech Stocks Rise as Snowflake Surges After $6 Billion Amazon Deal and Strong Earnings - The Motley Fool
Synopsys (NASDAQ:SNPS) Price Target Raised to $450.00 at BNP Paribas Exane - MarketBeat
Synopsys, Samsung Foundry expand manufacturing deal - Electronics360
Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026 - Synopsys
5 takeaways from Samsung Foundry’s design tie-up with SynopsysEDN - EDN - Voice of the Engineer
AI tools from Synopsys cut Samsung chip test cycles by up to 20% - Stock Titan
Synopsys Is the Worst S&P 500 Stock Today Despite Earnings Beat With AI and Merger in Focus - Barron's
Synopsys (NASDAQ:SNPS) Stock Price Down 6.8%Here's What Happened - MarketBeat
Synopsys, Inc. Stock 12‑Month Price Target Raised to $567.67, Implies 8% Upside - TradingView
Synopsys (SNPS) Delivers Strong Q2 Results, Analysts Remain Opti - GuruFocus
Synopsys Q2 Earnings Surpass Estimates, Revenues Rise Y/Y - The Globe and Mail
Synopsys delivers beat-and-raise, shares fall weakness in chip IP business - Yahoo! Finance Canada
Can Synopsys Stock Hit $700 This Year? - 24/7 Wall St.
Synopsys falls despite 'solid' Q2, outlook; analysts remain largely positive - MSN
Piper Sandler raises Synopsys stock price target on IP growth - Investing.com
KeyBanc reiterates Overweight on Synopsys stock on IP growth outlook - Investing.com
Bank of America Forecasts Strong Price Appreciation for Synopsys (NASDAQ:SNPS) Stock - MarketBeat
Synopsys Lifts Outlook, Cerebras Surges, JSR Sale Brews - Gotrade
Synopsys, Inc. Stock 12‑Month Price Target Raised to $565.43, Implies 8% Upside - TradingView
ARM vs. SNPS: Which AI Chip Design Stock Should Investors Buy? - TradingView
Synopsys (NASDAQ:SNPS) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Synopsys Beat Q2 2026 Estimates and Raised Guidance. What Comes Next for SNPS? - TIKR.com
Stifel raises Synopsys stock price target to $600 on results - Investing.com
Synopsys, Inc. (NASDAQ:SNPS) Q2 2026 Earnings Call Transcript - Insider Monkey
Why Synopsys (SNPS) Is Up 5.4% After Raising 2026 Outlook And Adding Elliott-Backed Director - Yahoo Finance
Rosenblatt reiterates Buy on Synopsys stock, keeps $575 target By Investing.com - Investing.com Nigeria
Deutsche Bank Adjusts Synopsys Price Target to $590 From $580, Maintains Buy Rating - marketscreener.com
BNP Paribas Adjusts Synopsys Price Target to $450 From $425, Maintains Underperform Rating - marketscreener.com
Synopsys, Inc. Q2 2026 Financial Results and Quarterly Report – Revenue, Earnings, and Business Highlights - Minichart
Rosenblatt reiterates Buy on Synopsys stock, keeps $575 target - Investing.com
Morgan Stanley Adjusts Price Target on Synopsys to $525 From $480, Maintains Equalweight Rating - marketscreener.com
Morgan Stanley raises Synopsys stock price target on co-design outlook - Investing.com Canada
Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust Purchases New Shares in Synopsys, Inc. $SNPS - MarketBeat
Synopsys, Inc. $SNPS Shares Sold by King Luther Capital Management Corp - MarketBeat
Wells Fargo Adjusts Price Target on Synopsys to $535 From $505, Maintains Equalweight Rating - marketscreener.com
Piper Sandler Adjusts Price Target on Synopsys to $450 From $430, Maintains Neutral Rating - marketscreener.com
Finanzdaten der Synopsys Inc-Aktie (SNPS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):